IMAGING OF VITELLIFORM MACULAR LESIONS USING POLARIZATION-SENSITIVE OPTICAL COHERENCE TOMOGRAPHY
暂无分享,去创建一个
U. Schmidt-Erfurth | C. Hitzenberger | M. Pircher | W. Schmidt | B. Baumann | S. Zotter | G. Mylonas | M. Ritter | R. Bittner | Philipp K Roberts | G. Deák | Philipp Roberts
[1] K. Tsunoda,et al. Clinical and Genetic Findings of Autosomal Recessive Bestrophinopathy in Japanese Cohort. , 2016, American journal of ophthalmology.
[2] S. Berland,et al. Biallelic Mutations in the BEST1 Gene: Additional Families with Autosomal Recessive Bestrophinopathy , 2016, Ophthalmic genetics.
[3] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[4] J. Pulido,et al. Autosomal Recessive Bestrophinopathy Is Not Associated With the Loss of Bestrophin-1 Anion Channel Function in a Patient With a Novel BEST1 Mutation. , 2015, Investigative ophthalmology & visual science.
[5] I. Chowers,et al. Adult-onset foveomacular vitelliform dystrophy: A fresh perspective , 2015, Progress in Retinal and Eye Research.
[6] You-xin Chen,et al. Screening for BEST1 gene mutations in Chinese patients with bestrophinopathy , 2014, Molecular vision.
[7] Markus Ritter,et al. RETINAL PIGMENT EPITHELIUM FINDINGS IN PATIENTS WITH ALBINISM USING WIDE-FIELD POLARIZATION-SENSITIVE OPTICAL COHERENCE TOMOGRAPHY , 2014, Retina.
[8] M. Parodi,et al. Fundus autofluorescence patterns in Best vitelliform macular dystrophy. , 2014, American journal of ophthalmology.
[9] R. T. Smith,et al. Quantitative fundus autofluorescence and optical coherence tomography in best vitelliform macular dystrophy. , 2014, Investigative ophthalmology & visual science.
[10] K. Freund,et al. Vitelliform macular dystrophy. , 2014, JAMA ophthalmology.
[11] Kuai Yu,et al. Differential effects of Best disease causing missense mutations on bestrophin-1 trafficking. , 2013, Human molecular genetics.
[12] Markus Ritter,et al. Characterization of stargardt disease using polarization-sensitive optical coherence tomography and fundus autofluorescence imaging. , 2013, Investigative ophthalmology & visual science.
[13] Christoph K. Hitzenberger,et al. Large-field high-speed polarization sensitive spectral domain OCT and its applications in ophthalmology , 2012, Biomedical optics express.
[14] I. MacDonald,et al. Phenotype and Genotype of Patients with Autosomal Recessive Bestrophinopathy , 2012, Ophthalmic genetics.
[15] Harald Sattmann,et al. Polarization sensitive optical coherence tomography of melanin provides intrinsic contrast based on depolarization , 2012, Biomedical optics express.
[16] Christian Ahlers,et al. MORPHOLOGIC CHARACTERISTICS OF IDIOPATHIC JUXTAFOVEAL TELANGIECTASIA USING SPECTRAL-DOMAIN AND POLARIZATION-SENSITIVE OPTICAL COHERENCE TOMOGRAPHY , 2012, Retina.
[17] U. Schmidt-Erfurth,et al. Polarization sensitive optical coherence tomography in the human eye , 2011, Progress in Retinal and Eye Research.
[18] O. Strauß,et al. Disease-associated missense mutations in bestrophin-1 affect cellular trafficking and anion conductance , 2011, Journal of Cell Science.
[19] M. Margaglione,et al. The spectrum of subclinical Best vitelliform macular dystrophy in subjects with mutations in BEST1 gene. , 2011, Investigative ophthalmology & visual science.
[20] Christian Ahlers,et al. Performance of automated drusen detection by polarization-sensitive optical coherence tomography. , 2011, Investigative ophthalmology & visual science.
[21] S. Ekvall,et al. Morphological and functional changes in multifocal vitelliform retinopathy and biallelic mutations in BEST1 , 2011, Ophthalmic genetics.
[22] D. Mackey,et al. AUTOSOMAL RECESSIVE VITELLIFORM MACULAR DYSTROPHY IN A LARGE COHORT OF VITELLIFORM MACULAR DYSTROPHY PATIENTS , 2011, Retina.
[23] E. Stone,et al. Autosomal recessive best vitelliform macular dystrophy: report of a family and management of early-onset neovascular complications. , 2011, Archives of ophthalmology.
[24] D. Mackey,et al. Best's macular dystrophy in Australia: phenotypic profile and identification of novel BEST1 mutations , 2011, Eye.
[25] L. Yannuzzi,et al. ACQUIRED VITELLIFORM LESIONS: Correlation of Clinical Findings and Multiple Imaging Analyses , 2011, Retina.
[26] Harald Sattmann,et al. Segmentation and quantification of retinal lesions in age-related macular degeneration using polarization-sensitive optical coherence tomography. , 2010, Journal of biomedical optics.
[27] E. Souied,et al. High-resolution spectral domain optical coherence tomography features in adult onset foveomacular vitelliform dystrophy , 2010, British Journal of Ophthalmology.
[28] S. Tsang,et al. Multimodal fundus imaging in Best vitelliform macular dystrophy , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.
[29] Christian Ahlers,et al. Imaging of the retinal pigment epithelium in age-related macular degeneration using polarization-sensitive optical coherence tomography. , 2010, Investigative ophthalmology & visual science.
[30] Thomas Theelen,et al. Fundus autofluorescence imaging of retinal dystrophies , 2008, Vision Research.
[31] U. Schmidt-Erfurth,et al. Retinal pigment epithelium segmentation by polarization sensitive optical coherence tomography. , 2008, Optics express.
[32] C K Hitzenberger,et al. Value of polarisation-sensitive optical coherence tomography in diseases affecting the retinal pigment epithelium , 2008, British Journal of Ophthalmology.
[33] H. C. Hartzell,et al. Chloride channel activity of bestrophin mutants associated with mild or late-onset macular degeneration. , 2007, Investigative ophthalmology & visual science.
[34] C. Wadelius,et al. Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2). , 2007, Experimental eye research.
[35] E. Stone,et al. Differential macular and peripheral expression of bestrophin in human eyes and its implication for best disease. , 2007, Investigative ophthalmology & visual science.
[36] V. Drouin‐Garraud,et al. New VMD2 gene mutations identified in patients affected by Best vitelliform macular dystrophy , 2006, Journal of Medical Genetics.
[37] B. Lorenz,et al. Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.
[38] N. Dahl,et al. Variant Phenotype of Best Vitelliform Macular Dystrophy Associated with Compound Heterozygous Mutations in VMD2 , 2006, Ophthalmic genetics.
[39] C. Hitzenberger,et al. High speed spectral domain polarization sensitive optical coherence tomography of the human retina. , 2005, Optics express.
[40] M. Killingsworth,et al. Adult vitelliform macular degeneration: a clinicopathological study , 2003, Eye.
[41] E. Souied,et al. Adult-onset foveomacular vitelliform dystrophy: a study by optical coherence tomography. , 2003, American journal of ophthalmology.
[42] G. Calori,et al. Optical coherence tomography findings in adult-onset foveomacular vitelliform dystrophy. , 2002, American journal of ophthalmology.
[43] D. Schorderet,et al. Identification of novel VMD2 gene mutations in patients with best vitelliform macular dystrophy , 2001, Human mutation.
[44] J. Hollyfield,et al. Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[45] Sander R. Dubovy,et al. ADULT‐ONSET FOVEOMACULAR PIGMENT EPITHELIAL DYSTROPHY: Clinicopathologic Correlation of Three Cases , 2000, Retina.
[46] A. Marquardt,et al. VMD2 mutations in vitelliform macular dystrophy (Best disease) and other maculopathies , 2000, Human mutation.
[47] B. Lorenz,et al. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration , 2000, European Journal of Human Genetics.
[48] C. Wadelius,et al. The mutation spectrum of the bestrophin protein – functional implications , 1999, Human Genetics.
[49] H. Stöhr,et al. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease). , 1998, Human molecular genetics.
[50] M. Metzker,et al. Identification of the gene responsible for Best macular dystrophy , 1998, Nature Genetics.
[51] G. Fishman,et al. Histopathologic findings in Best's vitelliform macular dystrophy. , 1988, Archives of ophthalmology.
[52] G. Jaffe,et al. Histopathologic features of adult-onset foveomacular pigment epithelial dystrophy. , 1988, Archives of ophthalmology.
[53] R. L. Font,et al. Foveomacular vitelliform dystrophy, adult type. A clinicopathologic study including electron microscopic observations. , 1985, Ophthalmology.
[54] S. Fine,et al. A histopathologic study of Best's macular dystrophy. , 1982, Archives of ophthalmology.
[55] J. Kobrin,et al. Histopathology of Best's macular dystrophy. , 1982, Archives of ophthalmology.
[56] D. A. Snyder,et al. Vitelliform lesions associated with retinal pigment epithelial detachment. , 1978, Annals of ophthalmology.
[57] A. Ahuja,et al. Progress in retinal and eye research , 1994 .
[58] D. M. Gass,et al. A clinicopathologic study of a peculiar foveomacular dystrophy. , 1974, Transactions of the American Ophthalmological Society.